Advanced Nano Products（A121600）株式概要アドバンスト・ナノ・プロダクツ社は、ディスプレイ、半導体、二次電池、太陽電池などのハイテク素材を韓国内外で製造・販売している。 詳細A121600 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長5/6過去の実績1/6財務の健全性4/6配当金0/6報酬収益は年間99.43%増加すると予測されています 今年は黒字化を達成 リスク分析財務結果に影響を与える大きな一時的項目 すべてのリスクチェックを見るA121600 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₩Current Price₩70.50k67.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-2b549b2016201920222025202620282031Revenue ₩549.3bEarnings ₩33.2bAdvancedSet Fair ValueView all narrativesAdvanced Nano Products Co., Ltd. 競合他社Dongsung FineTecSymbol: KOSDAQ:A033500Market cap: ₩651.8bENF TechnologySymbol: KOSDAQ:A102710Market cap: ₩688.7bTKG HuchemsSymbol: KOSE:A069260Market cap: ₩660.7bSoulbrain HoldingsSymbol: KOSDAQ:A036830Market cap: ₩989.0b価格と性能株価の高値、安値、推移の概要Advanced Nano Products過去の株価現在の株価₩70,500.0052週高値₩95,300.0052週安値₩44,600.00ベータ0.801ヶ月の変化-18.12%3ヶ月変化-1.26%1年変化43.15%3年間の変化-48.05%5年間の変化148.24%IPOからの変化607.36%最新ニュースNew Risk • 1hNew minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 27% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company.Price Target Changed • May 14Price target increased by 13% to ₩97,500Up from ₩86,500, the current price target is an average from 2 analysts. New target price is 29% above last closing price of ₩75,800. Stock is up 41% over the past year. The company is forecast to post earnings per share of ₩711 for next year compared to ₩136 last year.New Risk • Apr 24New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).Major Estimate Revision • Apr 11Consensus EPS estimates fall by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from ₩159.0m to ₩148.6m. EPS estimate also fell from ₩1,037 per share to ₩681 per share. Net income forecast to grow 512% next year vs 62% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩82,667 to ₩79,333. Share price rose 9.6% to ₩68,800 over the past week.Reported Earnings • Mar 20Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: ₩136 (up from ₩155 loss in FY 2024). Revenue: ₩111.7b (up 27% from FY 2024). Net income: ₩1.63b (up ₩3.49b from FY 2024). Profit margin: 1.5% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 78%. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.Buy Or Sell Opportunity • Feb 20Now 20% undervaluedOver the last 90 days, the stock has risen 31% to ₩71,200. The fair value is estimated to be ₩89,363, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.最新情報をもっと見るRecent updatesNew Risk • 1hNew minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 27% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company.Price Target Changed • May 14Price target increased by 13% to ₩97,500Up from ₩86,500, the current price target is an average from 2 analysts. New target price is 29% above last closing price of ₩75,800. Stock is up 41% over the past year. The company is forecast to post earnings per share of ₩711 for next year compared to ₩136 last year.New Risk • Apr 24New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).Major Estimate Revision • Apr 11Consensus EPS estimates fall by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from ₩159.0m to ₩148.6m. EPS estimate also fell from ₩1,037 per share to ₩681 per share. Net income forecast to grow 512% next year vs 62% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩82,667 to ₩79,333. Share price rose 9.6% to ₩68,800 over the past week.Reported Earnings • Mar 20Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: ₩136 (up from ₩155 loss in FY 2024). Revenue: ₩111.7b (up 27% from FY 2024). Net income: ₩1.63b (up ₩3.49b from FY 2024). Profit margin: 1.5% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 78%. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.Buy Or Sell Opportunity • Feb 20Now 20% undervaluedOver the last 90 days, the stock has risen 31% to ₩71,200. The fair value is estimated to be ₩89,363, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.New Risk • Feb 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.分析記事 • Feb 06Revenues Tell The Story For Advanced Nano Products Co., Ltd. (KOSDAQ:121600) As Its Stock Soars 32%Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shares have had a really impressive month, gaining 32% after a shaky...Buy Or Sell Opportunity • Jan 30Now 22% undervaluedOver the last 90 days, the stock has risen 4.9% to ₩69,100. The fair value is estimated to be ₩88,516, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.分析記事 • Jan 22The Returns On Capital At Advanced Nano Products (KOSDAQ:121600) Don't Inspire ConfidenceTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Upcoming Dividend • Dec 22Upcoming dividend of ₩250 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).New Risk • Dec 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.分析記事 • Dec 01These 4 Measures Indicate That Advanced Nano Products (KOSDAQ:121600) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Declared Dividend • Nov 08Dividend of ₩250 announcedDividend of ₩250 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 0.4%, which is lower than the industry average of 1.7%.分析記事 • Nov 07After Leaping 33% Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Shares Are Not Flying Under The RadarAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shares have had a really impressive month, gaining 33% after a shaky...お知らせ • Nov 07Advanced Nano Products Co., Ltd. announces Annual dividend, payable on April 13, 2026Advanced Nano Products Co., Ltd. announced Annual dividend of KRW 250.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.分析記事 • Sep 16Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Earnings Haven't Escaped The Attention Of InvestorsAdvanced Nano Products Co., Ltd.'s ( KOSDAQ:121600 ) price-to-sales (or "P/S") ratio of 6.1x may look like a poor...分析記事 • Aug 11These 4 Measures Indicate That Advanced Nano Products (KOSDAQ:121600) Is Using Debt ExtensivelyKOSDAQ:A121600 1 Year Share Price vs Fair Value Explore Advanced Nano Products's Fair Values from the Community and...Price Target Changed • May 13Price target decreased by 36% to ₩95,000Down from ₩148,750, the current price target is an average from 4 analysts. New target price is 78% above last closing price of ₩53,400. Stock is down 52% over the past year. The company is forecast to post earnings per share of ₩492 next year compared to a net loss per share of ₩155 last year.Buy Or Sell Opportunity • Apr 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to ₩53,900. The fair value is estimated to be ₩67,935, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company became loss making.New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.分析記事 • Apr 02Why We're Not Concerned Yet About Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) 25% Share Price PlungeAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders won't be pleased to see that the share price has had a...Buy Or Sell Opportunity • Apr 02Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.8% to ₩53,000. The fair value is estimated to be ₩66,936, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Mar 26Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: ₩155 loss per share (down from ₩1,489 profit in FY 2023). Revenue: ₩87.8b (up 5.5% from FY 2023). Net loss: ₩1.85b (down 111% from profit in FY 2023). Revenue missed analyst estimates by 12%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 46% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.お知らせ • Mar 05Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 31, 2025Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 31, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 243-2, techno jungang-ro, yuseong-gu, daejeon South KoreaBuy Or Sell Opportunity • Dec 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 38% to ₩58,200. The fair value is estimated to be ₩73,353, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 143% in 2 years. Earnings are forecast to grow by 625% in the next 2 years.Upcoming Dividend • Dec 20Upcoming dividend of ₩250 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 14 April 2025. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).分析記事 • Nov 15Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Shares Slammed 28% But Getting In Cheap Might Be Difficult RegardlessAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders that were waiting for something to happen have been...Valuation Update With 7 Day Price Move • Nov 11Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩75,900, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩73,855 per share.Buy Or Sell Opportunity • Nov 05Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 7.1% to ₩90,000. The fair value is estimated to be ₩74,944, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 182% in 2 years. Earnings are forecast to grow by 228% in the next 2 years.分析記事 • Oct 20Calculating The Intrinsic Value Of Advanced Nano Products Co., Ltd. (KOSDAQ:121600)Key Insights Advanced Nano Products' estimated fair value is ₩74,447 based on 2 Stage Free Cash Flow to Equity Current...分析記事 • Sep 26Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Popularity With Investors Is ClearWhen you see that almost half of the companies in the Chemicals industry in Korea have price-to-sales ratios (or "P/S...分析記事 • Sep 02Advanced Nano Products (KOSDAQ:121600) Will Want To Turn Around Its Return TrendsTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩74,900, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 100% over the past three years.Price Target Changed • Jun 11Price target decreased by 8.9% to ₩183,333Down from ₩201,333, the current price target is an average from 3 analysts. New target price is 52% above last closing price of ₩120,300. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₩1,481 for next year compared to ₩1,489 last year.New Risk • May 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 15% Last year net profit margin: 25% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (53% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (15% net profit margin). Shareholders have been diluted in the past year (13% increase in shares outstanding).分析記事 • Mar 23Advanced Nano Products' (KOSDAQ:121600) Problems Go Beyond Poor ProfitAfter announcing weak earnings, Advanced Nano Products Co., Ltd.'s ( KOSDAQ:121600 ) stock was strong. Despite the...分析記事 • Mar 21Revenues Tell The Story For Advanced Nano Products Co., Ltd. (KOSDAQ:121600) As Its Stock Soars 33%Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders would be excited to see that the share price has had a...Reported Earnings • Mar 20Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: ₩1,489 (down from ₩1,811 in FY 2022). Revenue: ₩83.2b (up 4.1% from FY 2022). Net income: ₩16.8b (down 13% from FY 2022). Profit margin: 20% (down from 24% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) exceeded analyst estimates by 1.4%. Revenue is forecast to grow 63% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Mar 15Some Investors May Be Worried About Advanced Nano Products' (KOSDAQ:121600) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...New Risk • Feb 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Profit margins are more than 30% lower than last year (15% net profit margin). Shareholders have been diluted in the past year (12% increase in shares outstanding).Upcoming Dividend • Dec 20Upcoming dividend of ₩250 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 15 April 2024. Payout ratio is a comfortable 23% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩377 (vs ₩952 in 3Q 2022)Third quarter 2023 results: EPS: ₩377 (down from ₩952 in 3Q 2022). Revenue: ₩20.5b (down 4.8% from 3Q 2022). Net income: ₩4.40b (down 56% from 3Q 2022). Profit margin: 21% (down from 47% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 66% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 58% per year whereas the company’s share price has increased by 54% per year.New Risk • Sep 10New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (11% increase in shares outstanding).New Risk • Jun 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 7.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Shareholders have been diluted in the past year (7.3% increase in shares outstanding).Reported Earnings • Mar 23Full year 2022 earnings released: EPS: ₩1,811 (vs ₩703 in FY 2021)Full year 2022 results: EPS: ₩1,811 (up from ₩703 in FY 2021). Revenue: ₩79.9b (up 31% from FY 2021). Net income: ₩19.2b (up 158% from FY 2021). Profit margin: 24% (up from 12% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 52% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has increased by 145% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩109,200, the stock trades at a trailing P/E ratio of 53x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 486% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩146,761 per share.Upcoming Dividend • Dec 21Upcoming dividend of ₩120 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 5.8% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Sep 19Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩81,500, the stock trades at a trailing P/E ratio of 60x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 436% over the past three years.Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩96,900, the stock trades at a trailing P/E ratio of 71.4x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 489% over the past three years.Valuation Update With 7 Day Price Move • Jul 01Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩67,400, the stock trades at a trailing P/E ratio of 78.5x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 265% over the past three years.Reported Earnings • May 18First quarter 2022 earnings released: EPS: ₩371 (vs ₩216 in 1Q 2021)First quarter 2022 results: EPS: ₩371 (up from ₩216 in 1Q 2021). Revenue: ₩18.8b (up 29% from 1Q 2021). Net income: ₩3.93b (up 73% from 1Q 2021). Profit margin: 21% (up from 16% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 64%, compared to a 23% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Apr 27Price target increased to ₩110,000Up from ₩90,000, the current price target is provided by 1 analyst. New target price is 60% above last closing price of ₩68,800. Stock is up 112% over the past year. The company posted earnings per share of ₩703 last year.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩51,300, the stock trades at a trailing P/E ratio of 79.4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 203% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%).お知らせ • May 25Advanced Nano Products Co., Ltd. announced that it expects to receive KRW 2.00006714 billion in funding from KDB Capital Corporation, Investment ArmAdvanced Nano Products Co., Ltd. (KOSDAQ:A121600) announced that it will issue 68,620 redeemable preferred stock of face value of KRW 500 per share at issue price of KRW 29,147 per share for gross proceeds of KRW 2,000,067,140 on May 24, 2021. The transaction will include participation from KDB Capital Corporation, Investment Arm. The transaction is through third party allotment method. The preferred shares will be redeemable at KRW 29,147 per share beginning from December 1, 2024 to December 31, 2024. The transaction is expected to close on June 25, 2021. The eligibility data for dividend payout on new shares is January 1, 2021. The transaction has been approved by the board of directors of the company. The preferred shares are subject to a lock up period of one year.分析記事 • Apr 07Is Advanced Nano Products (KOSDAQ:121600) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Mar 16Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?Advanced Nano Products (KOSDAQ:121600) has had a great run on the share market with its stock up by a significant 20...分析記事 • Feb 23Investors In Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Should Consider This, FirstDividend paying stocks like Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) tend to be popular with investors, and...Is New 90 Day High Low • Feb 23New 90-day low: ₩31,250The company is down 4.0% from its price of ₩32,650 on 25 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.お知らせ • Feb 20Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 29, 2021Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 29, 2021, at 10:00 Korea Standard Time.分析記事 • Feb 02If You Had Bought Advanced Nano Products (KOSDAQ:121600) Shares A Year Ago You'd Have Earned 90% ReturnsAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders have seen the share price descend 12% over the month...分析記事 • Jan 12Is Advanced Nano Products (KOSDAQ:121600) Likely To Turn Things Around?There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Is New 90 Day High Low • Jan 11New 90-day high: ₩40,000The company is up 24% from its price of ₩32,350 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 32% over the same period.分析記事 • Dec 22Advanced Nano Products (KOSDAQ:121600) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Upcoming Dividend • Dec 22Upcoming Dividend of ₩120 Per ShareWill be paid on the 17th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.3% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.9%).Is New 90 Day High Low • Dec 21New 90-day high: ₩39,500The company is up 7.0% from its price of ₩36,800 on 22 September 2020. The South Korean market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.Is New 90 Day High Low • Oct 26New 90-day low: ₩27,500The company is down 2.0% from its price of ₩28,200 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.株主還元A121600KR ChemicalsKR 市場7D1.4%5.4%13.5%1Y43.1%56.4%190.8%株主還元を見る業界別リターン: A121600過去 1 年間で56.4 % の収益を上げたKR Chemicals業界を下回りました。リターン対市場: A121600は、過去 1 年間で190.8 % のリターンを上げたKR市場を下回りました。価格変動Is A121600's price volatile compared to industry and market?A121600 volatilityA121600 Average Weekly Movement12.6%Chemicals Industry Average Movement9.8%Market Average Movement9.5%10% most volatile stocks in KR Market16.6%10% least volatile stocks in KR Market4.9%安定した株価: A121600 、 KR市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: A121600の 週次ボラティリティ ( 13% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2000266Chang-Woo Parkwww.anapro.com株式会社アドバンスト・ナノ・プロダクツは、ディスプレイ、半導体、二次電池、太陽電池などのハイテク材料を韓国内外で製造・販売している。負極・正極MWCNT、複合材料に使用される導電材料スラリー、ディスプレイパネル、偏光板、プリズムシート、スマートフォン、太陽電池、プリント基板に使用される中空シリカを提供している；フレキシブルディスプレイ、プリント回路基板、マイクロ・ミニLED微小電極の生成、電磁シールド、タッチスクリーン電極に使用されるインクジェット金属インク、スマートグラス、太陽電池電極、フレキシブルディスプレイ、プリント回路基板に使用される銀ペースト、タッチスクリーン、透明導電フィルム、スマートウィンドウ、発熱フィルムに使用される銀ナノワイヤー。また、CMP用研磨スラリー用セリアスラリー、折りたたみ式携帯電話やテレビ用ディスプレイ、自動車用ディスプレイ、自動車・建築用ガラス用の反射防止コーティングソリューション、保護フィルム、包装製品、ディスプレイ、外装・内装建材、半導体トレイに使用される帯電防止コーティングソリューション、帯電防止フィルム、タッチパネル、ディスプレイ用の透明導電性酸化物、プラスチックフィルムやガラスへの絶縁コーティングソリューションも提供している。また、薄膜製造に使用される透明導電性セラミックスパッタリングターゲットも提供している。アドバンスト・ナノ・プロダクツ社は2000年に設立され、韓国の世宗に本社を置いている。もっと見るAdvanced Nano Products Co., Ltd. 基礎のまとめAdvanced Nano Products の収益と売上を時価総額と比較するとどうか。A121600 基礎統計学時価総額₩820.05b収益（TTM）₩7.38b売上高(TTM)₩122.13b114.9xPER（株価収益率6.9xP/SレシオA121600 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計A121600 損益計算書（TTM）収益₩122.13b売上原価₩81.92b売上総利益₩40.21bその他の費用₩32.84b収益₩7.38b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）613.42グロス・マージン32.93%純利益率6.04%有利子負債／自己資本比率36.5%A121600 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.4%現在の配当利回りn/a配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/28 10:00終値2026/05/28 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Advanced Nano Products Co., Ltd. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Choi Soon-HoEugene Investment & Securities Co Ltd.Yushin ParkHSBCWon Suk ChungiM Securities4 その他のアナリストを表示
New Risk • 1hNew minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 27% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company.
Price Target Changed • May 14Price target increased by 13% to ₩97,500Up from ₩86,500, the current price target is an average from 2 analysts. New target price is 29% above last closing price of ₩75,800. Stock is up 41% over the past year. The company is forecast to post earnings per share of ₩711 for next year compared to ₩136 last year.
New Risk • Apr 24New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).
Major Estimate Revision • Apr 11Consensus EPS estimates fall by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from ₩159.0m to ₩148.6m. EPS estimate also fell from ₩1,037 per share to ₩681 per share. Net income forecast to grow 512% next year vs 62% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩82,667 to ₩79,333. Share price rose 9.6% to ₩68,800 over the past week.
Reported Earnings • Mar 20Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: ₩136 (up from ₩155 loss in FY 2024). Revenue: ₩111.7b (up 27% from FY 2024). Net income: ₩1.63b (up ₩3.49b from FY 2024). Profit margin: 1.5% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 78%. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • Feb 20Now 20% undervaluedOver the last 90 days, the stock has risen 31% to ₩71,200. The fair value is estimated to be ₩89,363, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.
New Risk • 1hNew minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 27% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company.
Price Target Changed • May 14Price target increased by 13% to ₩97,500Up from ₩86,500, the current price target is an average from 2 analysts. New target price is 29% above last closing price of ₩75,800. Stock is up 41% over the past year. The company is forecast to post earnings per share of ₩711 for next year compared to ₩136 last year.
New Risk • Apr 24New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).
Major Estimate Revision • Apr 11Consensus EPS estimates fall by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from ₩159.0m to ₩148.6m. EPS estimate also fell from ₩1,037 per share to ₩681 per share. Net income forecast to grow 512% next year vs 62% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩82,667 to ₩79,333. Share price rose 9.6% to ₩68,800 over the past week.
Reported Earnings • Mar 20Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: ₩136 (up from ₩155 loss in FY 2024). Revenue: ₩111.7b (up 27% from FY 2024). Net income: ₩1.63b (up ₩3.49b from FY 2024). Profit margin: 1.5% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 78%. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • Feb 20Now 20% undervaluedOver the last 90 days, the stock has risen 31% to ₩71,200. The fair value is estimated to be ₩89,363, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Feb 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
分析記事 • Feb 06Revenues Tell The Story For Advanced Nano Products Co., Ltd. (KOSDAQ:121600) As Its Stock Soars 32%Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shares have had a really impressive month, gaining 32% after a shaky...
Buy Or Sell Opportunity • Jan 30Now 22% undervaluedOver the last 90 days, the stock has risen 4.9% to ₩69,100. The fair value is estimated to be ₩88,516, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.
分析記事 • Jan 22The Returns On Capital At Advanced Nano Products (KOSDAQ:121600) Don't Inspire ConfidenceTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Upcoming Dividend • Dec 22Upcoming dividend of ₩250 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).
New Risk • Dec 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
分析記事 • Dec 01These 4 Measures Indicate That Advanced Nano Products (KOSDAQ:121600) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Declared Dividend • Nov 08Dividend of ₩250 announcedDividend of ₩250 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 0.4%, which is lower than the industry average of 1.7%.
分析記事 • Nov 07After Leaping 33% Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Shares Are Not Flying Under The RadarAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shares have had a really impressive month, gaining 33% after a shaky...
お知らせ • Nov 07Advanced Nano Products Co., Ltd. announces Annual dividend, payable on April 13, 2026Advanced Nano Products Co., Ltd. announced Annual dividend of KRW 250.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
分析記事 • Sep 16Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Earnings Haven't Escaped The Attention Of InvestorsAdvanced Nano Products Co., Ltd.'s ( KOSDAQ:121600 ) price-to-sales (or "P/S") ratio of 6.1x may look like a poor...
分析記事 • Aug 11These 4 Measures Indicate That Advanced Nano Products (KOSDAQ:121600) Is Using Debt ExtensivelyKOSDAQ:A121600 1 Year Share Price vs Fair Value Explore Advanced Nano Products's Fair Values from the Community and...
Price Target Changed • May 13Price target decreased by 36% to ₩95,000Down from ₩148,750, the current price target is an average from 4 analysts. New target price is 78% above last closing price of ₩53,400. Stock is down 52% over the past year. The company is forecast to post earnings per share of ₩492 next year compared to a net loss per share of ₩155 last year.
Buy Or Sell Opportunity • Apr 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to ₩53,900. The fair value is estimated to be ₩67,935, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
分析記事 • Apr 02Why We're Not Concerned Yet About Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) 25% Share Price PlungeAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders won't be pleased to see that the share price has had a...
Buy Or Sell Opportunity • Apr 02Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.8% to ₩53,000. The fair value is estimated to be ₩66,936, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Mar 26Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: ₩155 loss per share (down from ₩1,489 profit in FY 2023). Revenue: ₩87.8b (up 5.5% from FY 2023). Net loss: ₩1.85b (down 111% from profit in FY 2023). Revenue missed analyst estimates by 12%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 46% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
お知らせ • Mar 05Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 31, 2025Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 31, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 243-2, techno jungang-ro, yuseong-gu, daejeon South Korea
Buy Or Sell Opportunity • Dec 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 38% to ₩58,200. The fair value is estimated to be ₩73,353, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 143% in 2 years. Earnings are forecast to grow by 625% in the next 2 years.
Upcoming Dividend • Dec 20Upcoming dividend of ₩250 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 14 April 2025. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).
分析記事 • Nov 15Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Shares Slammed 28% But Getting In Cheap Might Be Difficult RegardlessAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders that were waiting for something to happen have been...
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩75,900, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩73,855 per share.
Buy Or Sell Opportunity • Nov 05Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 7.1% to ₩90,000. The fair value is estimated to be ₩74,944, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 182% in 2 years. Earnings are forecast to grow by 228% in the next 2 years.
分析記事 • Oct 20Calculating The Intrinsic Value Of Advanced Nano Products Co., Ltd. (KOSDAQ:121600)Key Insights Advanced Nano Products' estimated fair value is ₩74,447 based on 2 Stage Free Cash Flow to Equity Current...
分析記事 • Sep 26Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Popularity With Investors Is ClearWhen you see that almost half of the companies in the Chemicals industry in Korea have price-to-sales ratios (or "P/S...
分析記事 • Sep 02Advanced Nano Products (KOSDAQ:121600) Will Want To Turn Around Its Return TrendsTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩74,900, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 100% over the past three years.
Price Target Changed • Jun 11Price target decreased by 8.9% to ₩183,333Down from ₩201,333, the current price target is an average from 3 analysts. New target price is 52% above last closing price of ₩120,300. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₩1,481 for next year compared to ₩1,489 last year.
New Risk • May 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 15% Last year net profit margin: 25% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (53% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (15% net profit margin). Shareholders have been diluted in the past year (13% increase in shares outstanding).
分析記事 • Mar 23Advanced Nano Products' (KOSDAQ:121600) Problems Go Beyond Poor ProfitAfter announcing weak earnings, Advanced Nano Products Co., Ltd.'s ( KOSDAQ:121600 ) stock was strong. Despite the...
分析記事 • Mar 21Revenues Tell The Story For Advanced Nano Products Co., Ltd. (KOSDAQ:121600) As Its Stock Soars 33%Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders would be excited to see that the share price has had a...
Reported Earnings • Mar 20Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: ₩1,489 (down from ₩1,811 in FY 2022). Revenue: ₩83.2b (up 4.1% from FY 2022). Net income: ₩16.8b (down 13% from FY 2022). Profit margin: 20% (down from 24% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) exceeded analyst estimates by 1.4%. Revenue is forecast to grow 63% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Mar 15Some Investors May Be Worried About Advanced Nano Products' (KOSDAQ:121600) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
New Risk • Feb 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Profit margins are more than 30% lower than last year (15% net profit margin). Shareholders have been diluted in the past year (12% increase in shares outstanding).
Upcoming Dividend • Dec 20Upcoming dividend of ₩250 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 15 April 2024. Payout ratio is a comfortable 23% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩377 (vs ₩952 in 3Q 2022)Third quarter 2023 results: EPS: ₩377 (down from ₩952 in 3Q 2022). Revenue: ₩20.5b (down 4.8% from 3Q 2022). Net income: ₩4.40b (down 56% from 3Q 2022). Profit margin: 21% (down from 47% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 66% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 58% per year whereas the company’s share price has increased by 54% per year.
New Risk • Sep 10New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (11% increase in shares outstanding).
New Risk • Jun 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 7.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Shareholders have been diluted in the past year (7.3% increase in shares outstanding).
Reported Earnings • Mar 23Full year 2022 earnings released: EPS: ₩1,811 (vs ₩703 in FY 2021)Full year 2022 results: EPS: ₩1,811 (up from ₩703 in FY 2021). Revenue: ₩79.9b (up 31% from FY 2021). Net income: ₩19.2b (up 158% from FY 2021). Profit margin: 24% (up from 12% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 52% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has increased by 145% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩109,200, the stock trades at a trailing P/E ratio of 53x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 486% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩146,761 per share.
Upcoming Dividend • Dec 21Upcoming dividend of ₩120 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 5.8% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Sep 19Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩81,500, the stock trades at a trailing P/E ratio of 60x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 436% over the past three years.
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩96,900, the stock trades at a trailing P/E ratio of 71.4x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 489% over the past three years.
Valuation Update With 7 Day Price Move • Jul 01Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩67,400, the stock trades at a trailing P/E ratio of 78.5x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 265% over the past three years.
Reported Earnings • May 18First quarter 2022 earnings released: EPS: ₩371 (vs ₩216 in 1Q 2021)First quarter 2022 results: EPS: ₩371 (up from ₩216 in 1Q 2021). Revenue: ₩18.8b (up 29% from 1Q 2021). Net income: ₩3.93b (up 73% from 1Q 2021). Profit margin: 21% (up from 16% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 64%, compared to a 23% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Apr 27Price target increased to ₩110,000Up from ₩90,000, the current price target is provided by 1 analyst. New target price is 60% above last closing price of ₩68,800. Stock is up 112% over the past year. The company posted earnings per share of ₩703 last year.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩51,300, the stock trades at a trailing P/E ratio of 79.4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 203% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%).
お知らせ • May 25Advanced Nano Products Co., Ltd. announced that it expects to receive KRW 2.00006714 billion in funding from KDB Capital Corporation, Investment ArmAdvanced Nano Products Co., Ltd. (KOSDAQ:A121600) announced that it will issue 68,620 redeemable preferred stock of face value of KRW 500 per share at issue price of KRW 29,147 per share for gross proceeds of KRW 2,000,067,140 on May 24, 2021. The transaction will include participation from KDB Capital Corporation, Investment Arm. The transaction is through third party allotment method. The preferred shares will be redeemable at KRW 29,147 per share beginning from December 1, 2024 to December 31, 2024. The transaction is expected to close on June 25, 2021. The eligibility data for dividend payout on new shares is January 1, 2021. The transaction has been approved by the board of directors of the company. The preferred shares are subject to a lock up period of one year.
分析記事 • Apr 07Is Advanced Nano Products (KOSDAQ:121600) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Mar 16Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?Advanced Nano Products (KOSDAQ:121600) has had a great run on the share market with its stock up by a significant 20...
分析記事 • Feb 23Investors In Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Should Consider This, FirstDividend paying stocks like Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) tend to be popular with investors, and...
Is New 90 Day High Low • Feb 23New 90-day low: ₩31,250The company is down 4.0% from its price of ₩32,650 on 25 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.
お知らせ • Feb 20Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 29, 2021Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 29, 2021, at 10:00 Korea Standard Time.
分析記事 • Feb 02If You Had Bought Advanced Nano Products (KOSDAQ:121600) Shares A Year Ago You'd Have Earned 90% ReturnsAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders have seen the share price descend 12% over the month...
分析記事 • Jan 12Is Advanced Nano Products (KOSDAQ:121600) Likely To Turn Things Around?There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Is New 90 Day High Low • Jan 11New 90-day high: ₩40,000The company is up 24% from its price of ₩32,350 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 32% over the same period.
分析記事 • Dec 22Advanced Nano Products (KOSDAQ:121600) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩120 Per ShareWill be paid on the 17th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.3% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.9%).
Is New 90 Day High Low • Dec 21New 90-day high: ₩39,500The company is up 7.0% from its price of ₩36,800 on 22 September 2020. The South Korean market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
Is New 90 Day High Low • Oct 26New 90-day low: ₩27,500The company is down 2.0% from its price of ₩28,200 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
